Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1995-03-02
1996-08-27
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C07F 9280
Patent
active
055501192
ABSTRACT:
The present invention relates to the N-phosphonomethyl substituted compounds of formula ##STR1##
REFERENCES:
patent: 5155100 (1992-10-01), Eriem et al.
patent: 5250522 (1993-10-01), De Lambert
patent: 5273990 (1993-12-01), De Lambert
patent: 5294632 (1994-03-01), Erion et al.
CA 121:281220a Preparation . . . inhibitors. Erion et al., pp 1091, 1994.
Chem Abst. 117(7):70275b, Nachev, 1991.
K. Shiosaki et al. DN&P 7(10) Dec. 1994 pp.593-601.
T. Fukami et al. Biorganic & Medicinal Chem. letters vol. 4, No. 10 pp. 1257-1262 (1994).
S. De Lambert et al. Biochemical & Biophysical Research Comm. vol. 204, No. 1 (1994) Oct. 14, 1994.
B. Weiss et al. Res. Comm. in chemical Pathology & Pharmacology vol. 52, No. 1 Apr. 1986.
FASEB Journal Absts Endothelin/Endothelin Receptors, Mar. 15, 1994, A184.
De Lombaert St ephane
Jeng Arco Y.
Ksander Gary M.
Ciba-Geigy Corporation
Gruenfeld Norbert
McKane Joseph K.
LandOfFree
Phosphono substituted tetrazole derivatives as ECE inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphono substituted tetrazole derivatives as ECE inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphono substituted tetrazole derivatives as ECE inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056268